Treatment with Lipo-EPI-LOX resulted in significant (p < 0.05) tumor growth inhibition beginning at day 12 and displayed a similar trend of significance from day 19 to day 33 in comparison to other treatments. This evidence concerns the gene LOX and neoplasm.